Claim 55% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
The latest announcement is out from Cambi ASA ( (DE:3W7) ).
Cambi ASA has signed a medium-sized contract with NCC to deliver two thermal hydrolysis process systems to the Malad wastewater treatment plant in Mumbai, India, formalising a previously announced letter of intent. The contract, valued in the NOK 50–100 million range, provides for equipment delivery in 2027 and supports Mumbai’s ongoing programme to modernise its wastewater treatment infrastructure.
The deal reinforces Cambi’s presence in the Indian wastewater market and underscores the growing international adoption of its thermal hydrolysis technology. By contributing to enhanced energy recovery and lower emissions at a major treatment facility, the contract strengthens Cambi’s position in the global biogas and sludge treatment segment and may support its long-term growth and market leadership ambitions.
More about Cambi ASA
Cambi ASA is a global supplier of biogas technology and solutions for wastewater treatment plants and anaerobic digestion facilities. The company’s patented thermal hydrolysis process boosts renewable energy output, cuts operating costs, and reduces greenhouse gas emissions, and its systems are deployed at more than 100 installations across 28 countries. Listed on Euronext Growth Oslo, Cambi focuses on technologies that are compatible with a wide range of biosolids outlets and resilient to evolving environmental regulations.
Average Trading Volume: 43,911
Current Market Cap: NOK3.07B
For an in-depth examination of 3W7 stock, go to TipRanks’ Overview page.